Biological activity of tyrosine-containing 2,5-diketopiperazines

Pharmazie

Volumn 60, Issue 4, 2005, Pages 305-309

  Kilian, G ^a   Jamie, H ^a   Brauns, S C A ^a   Dyason, K ^a   Milne, P J ^a  

^a NELSON MANDELA METROPOLITAN UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

2,5 PIPERAZINEDIONE; CALCIUM CHANNEL; CALCIUM ION; CYCLOPEPTIDE; CYCLOPHENYLALANYLTYROSINE; CYCLOTYROSYLTYROSINE; DIPEPTIDE; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ION CHANNEL; MU OPIATE RECEPTOR; PIPERAZINE DERIVATIVE; POTASSIUM CHANNEL; POTASSIUM ION; TRITIUM; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; CARDIOVASCULAR AGENT; DRUG DERIVATIVE; TYROSINE;

ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BINDING COMPETITION; CARDIOVASCULAR EFFECT; HELA CELL; ISOLATED HEART; NONHUMAN; PATCH CLAMP; PEPTIDE ANALYSIS; RAT; RECEPTOR BINDING; ALGORITHM; ANIMAL; BRAIN LEVEL; CELL MEMBRANE POTENTIAL; CORONARY ARTERY BLOOD FLOW; DRUG EFFECT; DRUG SCREENING; HEART; HEART MUSCLE CONDUCTION SYSTEM; HEART RATE; HUMAN; IN VITRO STUDY; LONG EVANS RAT; MALE; METABOLISM; SYNTHESIS; TUMOR CELL LINE;

ALGORITHMS; ANIMALS; ANTINEOPLASTIC AGENTS; BINDING, COMPETITIVE; BRAIN CHEMISTRY; CALCIUM CHANNELS; CARDIOVASCULAR AGENTS; CELL LINE, TUMOR; CORONARY CIRCULATION; DRUG EVALUATION, PRECLINICAL; DRUG SCREENING ASSAYS, ANTITUMOR; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; HEART; HEART CONDUCTION SYSTEM; HEART RATE; HUMANS; MALE; MEMBRANE POTENTIALS; PATCH-CLAMP TECHNIQUES; PIPERAZINES; POTASSIUM CHANNELS; RATS; RATS, LONG-EVANS; RECEPTORS, OPIOID, MU; TYROSINE;

EID: 19044389984     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Anteunis MJO (1978) The cyclic dipeptides. Proper model compounds in protein research. Bull Soc Chirn Belg 87: 627-650.
2. Blake AD, Bot G, Freeman JC, Reisine T (1997) Differential opioid agonist regulation of the mouse μ opioid receptor. J Biol Chem 272: 782-790.
3. Chalecka-Franaszek E, Weems HB, Crowder AT, Cox BM, Côté TE (2000) Immunoprecipitation of high-affinity, guanine nucleotide-sensitive, solubilized μ-opioid receptors from rat brain. J Neurochem 74: 1068-1078.
4. Chang K-J, Cuatrecasas P (1979) Multiple opiate receptors. J Biol Chem 254: 2610-2618.
5. Chang J-K, Fong BTW (1976) Opiate receptor affinities and behavioural effects of enkephalin: structure-activity relationship of ten synthetic peptide analogues. Life Sci 18: 1473-1482.
6. Chen JJ, Dymshitz J, Vasko MR (1997) Regulation of opioid receptors in rat sensory neurons in culture. Mol Pharmacol 51: 666-673.
7. Fallen EL, Elliott WC, Gorlin R (1967) Apparatus for study of ventricular function and metabolism in the isolated perfused rat heart. J Appl Physiol 22: 836-839.
8. Ferrari R, Cucchini F, Bolognesi R, Bachetti T, Boraso A, Bernocchi P, Gaia G, Visioli O (1994) How do calcium antagonists differ in clinical practice. Cardiovasc Drugs Ther 8 (supp 3): 565-575.
9. Graz MGC, Grant GD, Brauns, SC, Hunt, A, Jamie, H., Milne PJ (2000) Cyclic dipeptides in the induction of maturation for cancer therapy. J Pharm Pharmacol 52: 75-82.
10. Hamil OP, Marty A, Neher E, Sakman B, Sigworth FJ (1981) Improved patch clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflügers Arch 391: 85-100.
11. th Edn, Prentice-Hall International, USA, p. 165.
12. Kopple KD, Ghazarian HG (1968) A convenient synthesis of 2,5-piperazinediones. J Org Chem 33: 862-864.
13. Lagane B, Gaibelet G, Meilhoc E, Masson J-M, Cézanne L, Lopez A (2000) Role of sterols in modulating the human μ-opioid receptor in Saccaromyces cerevisiae. J Biol Chem 275: 33197-33200.
14. 3H]noradrenaline release from SH-SY5Y cells. Biochem Pharmacol 46: 1145-1150.
15. Lavie Y, Fiucci G, Liscovitch M (1998) Up-regulation of caveolae and caveolar constituents in multidrug-resistant cancer cells. J Biol Chem 243: 32380-32383.
16. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193: 265-275.
17. Lubbe WF, Daries PS, Opie LH (1978) Ventricular arryhthmias associated with coronary artery occlusion and reperfusion in the isolated perfused rat heart: a model for assessment of antifibrillatory action of antiarrhythmic agents. Cardiovascular Res 12: 237-247.
18. Milne PJ, Hunt AL, Rostoll K, van der Walt JJ, Graz CJM (1998) The biological activity of selected cyclic dipeptides. J Pharm Pharmacol 50: 1331-1337.
19. Mitra R, Morad R (1985) A uniform enzymatic method for dissociation of myocytes from hearts and stomachs of vertebrates. Am J Physiol 249: 1056-1060.
20. Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, Warren JT, Bokesch H, Kenney S, Boyd MR (1990) New colorimetric assay for anticancer-drug screening. J Natl Cancer Inst 82: 1107-1112.
21. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke, NM, Olson BJ, Klenk DC (1985) Measurement of protein using bicinchoninic acid. Anal Biochem 150: 76-85.
22. nd Edition. Kluwer Adademic Publishers, Norwell. P. 1009.
23. Ström K, Sjogren J, Broberg A, Schnurer J (2002) Lactobacillus plantarum MiLAB 393 produces the antifungal cyclic dipeptides cyclo(L-Phe-L-Pro) and cyclo(L-Phe-trans-4-OH-L-Pro) and 3-phenyllactic acid. Appl Environ Microbiol 68: 4322-4327.
24. Tytgat J (1994) How to isolate cardiac myocytes. Cardiovasc Res 28: 280-283.
25. Yamazaki T, Nunami K-I, Goodman M (1991) Cyclic retro-inverso dipeptides with two aromatic side chains. II. Conformational Analysis. Biopolymers 31: 1513-1528.